Cabozantinib product-specific bioequivalence guidance
This document provides product-specific guidance on the demonstration of the bioequivalence of cabozantinib tablet 20 mg, 40 mg and 60 mg.
Keywords: Bioequivalence, generics, cabozantinib
- BCS Classification: Biopharmaceutics Classification System
- AUC0-t: area under the plasma concentration curve from administration to last observed concentration at time t
- Cmax: maximum plasma concentration